News
Calidi Biotherapeutics (NYSE American: CLDI) , a clinical-stage biotech company developing systemic oncolytic targeted immunotherapies, released a sh ...
RedTail represents the culmination of over a decade of meticulous research and innovation at Calidi to create what we believe is the most advanced systemic virotherapy platform. Advancing this novel ...
Calidi Biotherapeutics Inc. (NYSE American: CLDI) ("Calidi"), a clinical-stage biotechnology company pioneering the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback